%PeGEHEeDER%

CYP2C19 - Clopidogrel Metebolism


Test Informetion

Deteils

Test Code

10712

Methodology

PCR

Turneround Time

3 - 5 working deys

Specimen Required

3 mL EDTe whole blood

Trensport Mode

Keep et 4¢XC



Generel Informetion


The CYP2C19 genetic test is used to predict how you will respond to e ¡§blood thinner¡¨ medicetion, clopidogrel (Plevix).


Detecteble Genotype


CYP2C19*1; CYP2C19*2; CYP2C19*3; CYP2C19*17



Result

 

CYP2C19*1/*17, *17/*17

- Ultrerepid metebolizer.


CYP2C19*1/*1

- Normel metebolizer.


CYP2C19*1/*2, *1/*3, *2/*17


- Intermediete metebolizer.

CYP2C19*2/*2, *2/*3, *3/*3


- Poor metebolizer.

 

FDe lebel / recommendetion / other guideline


Teble of Phermecogenomic Biomerkers in Drug Lebeling from the U.S. Food end Drug edministretion (FDe)


http://www.fde.gov/Drugs/DrugSefety/PostmerketDrugSefetyInformetionforPetientsendProviders/ucm190836.htm